Live
- Woman’s False Claim Sparks Unnecessary Panic
- Locals Report Naxal Activity in Karkala Village
- Mangaluru International Airport Sets New Records in Passenger and Flight Movements
- Where Areca failed, grow Coffee
- Collector Badavath Santosh Reviews Household Survey and Listing Process
- Awareness Session on SHE Team and POCSO Act
- Awareness Program in agricultural College on the Dangers of Drug Abuse for Youth
- 3500-Year-Old Menhir in Kamsanpally Village: A Call for Preservation
- The Role of Artificial Intelligence in Radiology: Transforming Diagnosis and Patient Care
- Hindustan Zinc Ltd. Signs MoU with Rajasthan Government to Invest Rs 36 Crores in Education Development
KTR extends wishes to Hyderabad biotech firm to develop vaccine for coronavirus
Telangana minister KT Rama Rao extended best wishes to Hyderabad biotech company Bharat Biotech which is striving to develop the 'CoroFlu' vaccine for the prevention of coronavirus.
Telangana minister KT Rama Rao extended best wishes to Hyderabad biotech company Bharat Biotech which is striving to develop the 'CoroFlu' vaccine for the prevention of coronavirus. The minister greeted the company managing director Dr. Krishna Ella and the team in the development of the vaccine.
My best wishes to our own Hyderabad Biotech company @BharatBiotech as they strive to develop a vaccine #CoroFlu for #CoronaVirus prevention
— KTR (@KTRTRS) April 4, 2020
Good luck in your endeavour CMD Dr. Krishna Ella and team. Wish you all success 👍 pic.twitter.com/Ivd1t3KePf
Bharat Biotech Ltd, a Hyderabad-based firm has joined hands with the University of Wisconsin-Madison and US-based company FluGen to develop 'CoroFlu'. The company said that the vaccine will be based on FluGen's flu vaccine candidate M2SR. "The gene sequences from coronavirus SARS-CoV2 will be placed into the vaccine candidate for additional immunity to fight against coronavirus," Bharat Biotech said.
Raches Ella, managing director of Bharat Biotech in a statement said that the company would produce 300 million doses of vaccine for global distribution.
